gerd and glp-1 drugs increase risk of acid reflux, GERD, study finds Experiencing heartburn while on GLP-1s?
Description
The regulatory environment for compounded GLP-1 medications is actively evolving as of May 2026
Egler, someone with an HbA1c of 5.6% may think theyre in-range, but their cardiometabolic risk is already meaningfully elevated
In adults with type 2 diabetes and heart disease, it is also used to reduce the risk of major cardiovascular events
In fact, some studies found that semaglutide (GLP-1 RA) medications helped people lose an average of 9%-17% of their body weight in a little over a year
